Cargando…
Non-alcoholic fatty liver disease – a procoagulant condition?
Non-alcoholic fatty liver disease (NAFLD) is associated with a number of extrahepatic comorbidities and considerable cardiovascular morbidity and mortality, which is possibly related to coagulation changes associated with metabolic syndrome. Coagulation disorders are common in patients with liver di...
Autores principales: | Virović-Jukić, Lucija, Stojsavljević-Shapeski, Sanja, Forgač, Jelena, Kukla, Michal, Mikolašević, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976878/ https://www.ncbi.nlm.nih.gov/pubmed/33660958 http://dx.doi.org/10.3325/cmj.2021.62.25 |
Ejemplares similares
-
Liver regeneration as treatment target for severe alcoholic hepatitis
por: Virovic-Jukic, Lucija, et al.
Publicado: (2022) -
Plexiglas barrier box to improve ERCP safety during the COVID-19 pandemic
por: Ljubicic, Neven, et al.
Publicado: (2020) -
New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
por: Stojsavljevic-Shapeski, Sanja, et al.
Publicado: (2021) -
The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
por: Mikolasevic, Ivana, et al.
Publicado: (2022) -
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
por: Ogresta, Doris, et al.
Publicado: (2022)